Results 201 to 210 of about 2,268,694 (237)
The exploration and research on the establishment of an early risk assessment system for high-risk diabetic feet. [PDF]
Qi H, Li J, Hou L, Huang R, Ma L.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
BioDrugs, 2003
CPH 82 [Reumacon] is a purified semi-synthetic lignan glycoside derivative of the medicinal herb Podophyllum emodi which inhibits microtubules. It has been jointly developed by the Swedish company Conpharm and the Swiss company Analytecon SA. It has potential for the treatment of rheumatoid arthritis.
openaire +2 more sources
CPH 82 [Reumacon] is a purified semi-synthetic lignan glycoside derivative of the medicinal herb Podophyllum emodi which inhibits microtubules. It has been jointly developed by the Swedish company Conpharm and the Swiss company Analytecon SA. It has potential for the treatment of rheumatoid arthritis.
openaire +2 more sources

